Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
ICICI Bank Limited

IBN

ICICI Bank Limited

ICICI Bank Limited historical holders

total: 6

Oaktree Capital Management ICICI Bank Limited transactions over time

Total transactions:
39
New positions:
1
Sold out:
1
Added:
20
Reduced:
17
Held since:
2014 Q3
Held for:
39 quarters
Latest activity:
2024 Q2
Howard Marks has been an institutional investor in ICICI Bank Limited (IBN) since 2014 Q3. According to 2026 Q1 report, Howard Marks doesn't hold any shares. The fund/company first acquired IBN in 2014 Q3, initially purchasing about 2.81M shares. Since the initial investment, Oaktree Capital Management has made 38 more transactions in this position.

When did Howard Marks exit their IBN position?

Howard Marks no longer holds ICICI Bank Limited (IBN). They sold off their entire position in 2024 Q2, closing out an investment that began in 2014 Q3.

When did Howard Marks first invest in IBN?

Howard Marks first invested in ICICI Bank Limited (IBN) in 2014 Q3 at the reported quarter-end price of $8.93 per share, acquiring 2,813,882 shares in their initial purchase.

What is Howard Marks's average cost basis for IBN?

Based on historical transaction data, Howard Marks's estimated cost basis for ICICI Bank Limited (IBN) is approximately $10.02 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$10.02
Weighted AVG sell price:
$17.17

IBN transactions history by Oaktree Capital Management

39 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2024 Q2
0.00%
0
$26.41
-100% (-2,851,796)
-1.21%
2024 Q1
1.21%
2,851,796
$26.41
$75,315,932
-5.97% (-181,073)
-0.08%
2023 Q4
1.14%
3,032,869
$23.84
$72,303,596
+8.61% (+240,411)
+0.09%
2023 Q3
0.98%
2,792,458
$23.12
$64,561,628
-29.87% (-1,189,531)
-0.37%
2023 Q2
1.25%
3,981,989
$23.08
$91,904,306
-2.14% (-87,279)
-0.02%
2023 Q1
0.99%
4,069,268
$21.58
$87,814,803
+4.07% (+159,071)
+0.04%
2022 Q4
0.93%
3,910,197
$21.89
$85,594,212
-3.73% (-151,467)
-0.04%
2022 Q3
0.96%
4,061,664
$20.97
$85,173,000
-20.61% (-1,054,532)
-0.26%
2022 Q2
1.08%
5,116,196
$17.74
$90,761,000
+22.76% (+948,607)
+0.2%
2022 Q1
0.84%
4,167,589
$18.94
$78,934,000
+1.41% (+58,138)
+0.01%
2021 Q4
0.94%
$19.79
-21.97% (-1,156,766)
2021 Q3
1.45%
$18.87
+3.86% (+195,908)
2021 Q2
1.17%
$17.10
-1.88% (-96,953)
2021 Q1
1.16%
$16.03
-16.03% (-986,791)
2020 Q4
1.58%
$14.86
+1.71% (+103,540)
2020 Q3
1.29%
$9.83
+15.23% (+799,502)
2020 Q2
1.08%
$9.29
+10.10% (+481,567)
2020 Q1
1.17%
$8.50
-17.89% (-1,039,446)
2019 Q4
1.70%
$15.09
-30.56% (-2,556,504)
2019 Q3
2.08%
$12.18
-3.13% (-270,516)
2019 Q2
2.20%
$12.59
-16.26% (-1,677,173)
2019 Q1
2.36%
$11.46
+9.64% (+906,841)
2018 Q4
1.85%
$10.29
-10.71% (-1,128,103)
2018 Q3
1.47%
$8.49
+8.14% (+792,833)
2018 Q2
1.09%
$8.03
+8.65% (+775,512)
2018 Q1
1.28%
$8.85
+1.84% (+161,684)
2017 Q4
1.37%
$9.73
+14.83% (+1,136,986)
2017 Q3
0.99%
$8.56
+5.38% (+391,464)
2017 Q2
1.07%
$8.96
-0.03% (-2,088.2)
2017 Q1
0.89%
$7.81
+3.63% (+255,049.3)
2016 Q4
0.72%
$6.81
+7.98% (+519,246.2)
2016 Q3
0.63%
$6.79
+42.80% (+1,949,135.1)
2016 Q2
0.54%
$6.51
-0.11% (-4,840)
2015 Q4
0.43%
$7.12
-8.11% (-402,348.1)
2015 Q3
0.50%
$7.62
+6.69% (+310,974.4)
2015 Q2
0.51%
$9.47
-16.31% (-906,070)
2015 Q1
0.55%
$9.42
+25.31% (+1,122,522.5)
2014 Q4
0.50%
$10.50
+57.59% (+1,620,402.3)
2014 Q3
0.42%
$8.93
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.